APOA4 Antikörper (AA 227-396)
Kurzübersicht für APOA4 Antikörper (AA 227-396) (ABIN6137000)
Target
Alle APOA4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 227-396
-
Sequenz
- AQDTQEKLNH QLEGLTFQMK KNAEELKARI SASAEELRQR LAPLAEDVRG NLRGNTEGLQ KSLAELGGHL DQQVEEFRRR VEPYGENFNK ALVQQMEQLR QKLGPHAGDV EGHLSFLEKD LRDKVNSFFS TFKEKESQDK TLSLPELEQQ QEQQQEQQQE QVQMLAPLES
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 227-396 of human APOA4 (NP_000473.2).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- APOA4 (Apolipoprotein A-IV (APOA4))
-
Andere Bezeichnung
- APOA4
-
Hintergrund
- Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro.,APOA4,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Heart,Lipids,Lipoproteins/Apolipoproteins,Cardiovascular diseases,Heart disease,APOA4
-
Molekulargewicht
- 45 kDa
-
Gen-ID
- 337
-
UniProt
- P06727
-
Pathways
- Lipid Metabolism
Target
-